Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5OMZ

Solution structure of domain III (DIII)of Zika virus Envelope protein

Summary for 5OMZ
Entry DOI10.2210/pdb5omz/pdb
NMR InformationBMRB: 34167
DescriptorEnvelope Protein (1 entity in total)
Functional Keywordszika virus envelope protein domain, viral protein, zikv
Biological sourceZika virus (strain Mr 766) (ZIKV)
Total number of polymer chains1
Total formula weight12479.39
Authors
Zerbe, O.,Bardelli, M. (deposition date: 2017-08-02, release date: 2017-10-04, Last modification date: 2024-06-19)
Primary citationWang, J.,Bardelli, M.,Espinosa, D.A.,Pedotti, M.,Ng, T.S.,Bianchi, S.,Simonelli, L.,Lim, E.X.Y.,Foglierini, M.,Zatta, F.,Jaconi, S.,Beltramello, M.,Cameroni, E.,Fibriansah, G.,Shi, J.,Barca, T.,Pagani, I.,Rubio, A.,Broccoli, V.,Vicenzi, E.,Graham, V.,Pullan, S.,Dowall, S.,Hewson, R.,Jurt, S.,Zerbe, O.,Stettler, K.,Lanzavecchia, A.,Sallusto, F.,Cavalli, A.,Harris, E.,Lok, S.M.,Varani, L.,Corti, D.
A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential.
Cell, 171:229-241.e15, 2017
Cited by
PubMed Abstract: Zika virus (ZIKV), a mosquito-borne flavivirus, causes devastating congenital birth defects. We isolated a human monoclonal antibody (mAb), ZKA190, that potently cross-neutralizes multi-lineage ZIKV strains. ZKA190 is highly effective in vivo in preventing morbidity and mortality of ZIKV-infected mice. NMR and cryo-electron microscopy show its binding to an exposed epitope on DIII of the E protein. ZKA190 Fab binds all 180 E protein copies, altering the virus quaternary arrangement and surface curvature. However, ZIKV escape mutants emerged in vitro and in vivo in the presence of ZKA190, as well as of other neutralizing mAbs. To counter this problem, we developed a bispecific antibody (FIT-1) comprising ZKA190 and a second mAb specific for DII of E protein. In addition to retaining high in vitro and in vivo potencies, FIT-1 robustly prevented viral escape, warranting its development as a ZIKV immunotherapy.
PubMed: 28938115
DOI: 10.1016/j.cell.2017.09.002
PDB entries with the same primary citation
Experimental method
SOLUTION NMR
Structure validation

238582

PDB entries from 2025-07-09

PDB statisticsPDBj update infoContact PDBjnumon